The 3 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 24.00, with a high estimate of 34.00 and a low estimate of 19.00. The median estimate represents a +32.30% increase from the last price of 18.14.
The current consensus among 4 polled investment analysts is to Buy stock in Meridian Bioscience Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.17
Reporting Date Nov 05
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.